Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

XTL Biopharmaceuticals reviews recent developments

Dec. 22, 2003

Septic diaphragm dysfunction attenuated with geranylgernaylacetone induction of HSD70 in rats

Dec. 22, 2003

Genelabs patent covers new NS5B inhibitors for HCV infection

Dec. 22, 2003

Interim analysis reported for Infergen/Actimmune in hepatitis C nonresponders

Dec. 19, 2003

Novel 5-HT4 agonist with good safety profile and its use in GI motility disorders

Dec. 18, 2003

Pariet submitted for ZES and pathological hypersecretory conditions in Europe

Dec. 18, 2003

Chugai launches Pegasys in Japan

Dec. 17, 2003

Phase II results for Itax confirm earlier safety and efficacy findings

Dec. 17, 2003

Compositions of lafutidine for IBD

Dec. 16, 2003

Spring Bank acquires rights to MBI-1313 for HBV from Micrologix

Dec. 15, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...